Strong Balance Sheet Stocks

Results

1721

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

1721 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	6652	NT$1.96	0%	-67.7%	NT$268.5m	n/a	129.3	n/a	n/a	Pharmaceuticals & Biotech
	7551	NT$13.05	0%	-16.3%	NT$151.9m	n/a	0.8	n/a	0%	Media
	6832	NT$63.50	-9.3%	53.4%	NT$2.0b	n/a	20.2	n/a	2.5%	Materials
	1269	NT$66.00	-0.6%	-4.8%	NT$1.4b	n/a	16.0	n/a	6.1%	Consumer Services
	7776	NT$30.15	0.5%	-22.4%	NT$1.5b	n/a	91.0	n/a	n/a	Pharmaceuticals & Biotech
	6709	NT$23.40	-6.0%	9.9%	NT$1.5b	n/a	9.1	n/a	n/a	Pharmaceuticals & Biotech
	7878	NT$122.50	-29.6%	n/a	NT$10.1b	n/a	10.9	n/a	n/a	Pharmaceuticals & Biotech
	7759	NT$28.45	-4.2%	-59.8%	NT$2.1b	n/a	4.2	n/a	n/a	Pharmaceuticals & Biotech
	3184	NT$13.65	-2.8%	2.1%	NT$949.3m	n/a	28.6	n/a	1.6%	Healthcare
	6428	NT$20.85	-11.7%	86.2%	NT$448.3m	n/a	23.6	n/a	0%	Media
	7808	NT$29.45	-1.8%	-41.9%	NT$2.2b	n/a	13.3	n/a	n/a	Pharmaceuticals & Biotech
	6750	NT$52.20	-8.3%	-0.6%	NT$2.5b	n/a	10.3	n/a	6.7%	Capital Goods
	6926	NT$63.00	-0.2%	-5.3%	NT$3.1b	n/a	104.6	n/a	n/a	Pharmaceuticals & Biotech
	7832	NT$11.90	-4.4%	19.0%	NT$7.1b	n/a	2890.3	n/a	n/a	Pharmaceuticals & Biotech
	1459	NT$11.85	0%	0.9%	NT$3.8b	n/a	7.9	n/a	1.7%	Consumer Durables
	6589	NT$44.85	-1.6%	-28.9%	NT$13.6b	NT$111.00	12.0	115.4%	n/a	Pharmaceuticals & Biotech
	6139	NT$707.00	-15.8%	114.9%	NT$166.6b	NT$1,500.00	19.6	41.7%	3.3%	Commercial Services
	1227	NT$29.25	0.2%	-8.0%	NT$26.6b	n/a	20.0	n/a	4.6%	Food, Beverage & Tobacco
	2516	NT$14.05	-0.7%	-10.5%	NT$3.2b	n/a	12.0	n/a	0%	Capital Goods
	9960	NT$32.00	0%	32.2%	NT$1.1b	n/a	17.1	n/a	4.8%	Retail
	6986	NT$44.50	-0.8%	-35.4%	NT$2.0b	n/a	18.3	n/a	0.5%	Pharmaceuticals & Biotech
	6517	NT$62.40	-4.9%	-12.2%	NT$1.9b	n/a	46.5	n/a	2.4%	Tech
	2349	NT$10.65	-5.3%	3.9%	NT$7.4b	n/a	1.0	n/a	n/a	Tech
	7777	NT$36.90	-6.6%	161.1%	NT$6.9b	n/a	58.6	n/a	0.07%	Diversified Financials

Page 1 of 48